Reviewing 111 (NASDAQ:YI) & Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health (NYSE:HIMS) and 111 (NASDAQ:YI) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership.

Volatility and Risk

Hims & Hers Health has a beta of 2.43, indicating that its share price is 143% more volatile than the S&P 500. Comparatively, 111 has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Hims & Hers Health and 111, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	4	9	3	1	2.06
111	1	0	0	0	1.00

Hims & Hers Health presently has a consensus price target of $42.62, indicating a potential upside of 74.51%. Given Hims & Hers Health’s stronger consensus rating and higher possible upside, research analysts plainly believe Hims & Hers Health is more favorable than 111.

Profitability

This table compares Hims & Hers Health and 111’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	6.05%	24.67%	9.37%
111	-0.52%	N/A	-2.70%

Earnings & Valuation

This table compares Hims & Hers Health and 111″s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$1.48 billion	3.77	$126.04 million	$0.54	45.22
111	$1.97 billion	0.03	-$1.42 million	($0.84)	-9.08

Hims & Hers Health has higher earnings, but lower revenue than 111. 111 is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 21.3% of 111 shares are held by institutional investors. 13.7% of Hims & Hers Health shares are held by insiders. Comparatively, 43.9% of 111 shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Hims & Hers Health beats 111 on 13 of the 15 factors compared between the two stocks.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

About 111

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.